Wave Life Sciences, Inc. (WVE) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Wave Life Sciences, Inc. (WVE) closed at USD 3.09 on 2026-10-14, a change of -59.3 % over the past year, with a market capitalization of USD 628.58M.

Wave Life Sciences, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Wave Life Sciences, Inc. key figures

Previous close

USD 3.09 (2026-10-14)

1-year change

-59.3 %

Market cap

USD 628.58M

Enterprise value

USD 181.57M

P/E ratio (trailing)

-2.90

P/E ratio (forward)

-2.75

EPS (trailing)

-1.10

EPS (forward)

-1.16

PEG ratio

n/a

Price to book

1.36

Revenue growth

-73.9 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

5.45

Employees

317

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Wave Life Sciences, Inc.

Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscular dystrophy and Huntington's disease, as well as various preclinical programs utilizing its RNA medicines platform. Wave Life Sciences, Inc. was founded in 2012 and is headquartered in Cambridge, Massachusetts.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Wave Life Sciences, Inc. and compare it with other stocks.